Skip to content
Screener

MiMedx Group MDXG EPS (Diluted)

EPS (Diluted) at other companies

IAR
Integra LifeSciencesIART
$0.06+101%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
-$0.08-100%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$0.77-670%
Solventum logo
SolventumSOLV
$0.53+3.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$0.05+600%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$0.05+78.3%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other expense, net(102)(101)(270)(247)
(Loss) income before income tax(17,780)13,007(33,111)21,617
Income tax benefit (provision)2,940(3,389)7,411(4,978)
Net (loss) income$(14,840)$9,618$(25,700)$16,639
Basic net (loss) income per common share$(0.10)$0.07$(0.17)$0.11
Diluted net (loss) income per common share$(0.10)$0.06$(0.17)$0.11
Weighted average common shares outstanding - basic147,795,741147,761,332148,119,083147,518,179
Weighted average common shares outstanding - diluted147,795,741149,317,281148,119,083149,529,544

Item 1. Financial Statements

FAQ

What is MiMedx Group's EPS (diluted)?
MiMedx Group (MDXG) reported EPS (diluted) of -$0.10 in Q2 2026.
How has MiMedx Group's EPS (diluted) changed year-over-year?
MiMedx Group's EPS (diluted) decreased by 266.7% year-over-year, from $0.06 to -$0.10.
What is the long-term trend for MiMedx Group's EPS (diluted)?
Over 4 years (2021 to 2025), MiMedx Group's EPS (diluted) has grown at a 18.9% compound annual growth rate (CAGR), from -$0.16 to $0.32.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about MiMedx Group's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude